Ensysce Biosciences Inc. Gains 96.26%
Wed, Apr 23, 2025 at 08:08 PM
Ensysce Biosciences Inc. (ENSC:NASDAQ) shot up at $3.67, representing a gain of 96.3%. On Wed, Apr 23, 2025, ENSC:NASDAQ hit a New 2-Week High of $3.67. The stock appeared on our News Catalysts scanner on Wed, Apr 23, 2025 at 07:09 PM in the 'PRIVATE PLACEMENT' category. From Wed, Apr 09, 2025, the stock recorded 55.56% Up Days and 30.00% Green Days
The stock spiked on Wed, Apr 23, 2025 at $4.85 with a volume of 91M+.
About Ensysce Biosciences Inc. (ENSC:NASDAQ)
Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs.
Top 10 Gainers:
- Jayud Global Logistics Limited (JYD:NASDAQ), 160.2%
- Smart for Life Inc. (SMFL:NASDAQ), 150%
- Ensysce Biosciences Inc. (ENSC:NASDAQ), 96.26%
- AGM Group Holdings Inc. (AGMH:NASDAQ), 93.33%
- Sonoma Pharmaceuticals, Inc. (SNOA:NASDAQ), 69.53%
- Cantor Equity Partners Inc. (CEP:NASDAQ), 54.21%
- EPWK Holdings Ltd. (EPWK:NASDAQ), 50.65%
- AgriFORCE Growing Systems Ltd. (AGRI:NASDAQ), 49.31%
- Biomotion Sciences (SLXN:NASDAQ), 43.94%
- Pluri Inc Com (PLUR:NASDAQ), 40.63%